Chione
Chione
Investment Fund Manager | Guernsey | Health Improvement
Overview
Supporting the development of medical diagnostic pharmaceutical and IT technologies world wide. Chione is an investor in Karyopharm Therapeutics and Metamark Genetics
Investor Type |
Legal Structure |
Operating Status |
Members |
| Investment Fund Manager | Holding Company | Operating |
Portfolio
Aug, 2015
Joint Equity PRI
Sera Prognostics
Testing for Premature Birth Risk
Sera Prognostics is a private biotechnology company developing...
sector
Women and Girls
Health Improvement
regions
United States of America
People
Investors / Funders
Team
Funds
Impact
Geographies:
Social Objectives:
Environmental Objectives:
Operational Impact:
Impact Reports & Metrics
Offices
Headquarters :
SIMOU MENARDOU 8 RIA COURT 8
OFFICE 101 6015
LARNACA
G4 CY
Cyprus